CD20 is a direct regulator of B-cell receptor signaling in the microenvironment of chronic lymphocytic leukemia

PAVLASOVÁ, Gabriela, Veronika SVOBODOVÁ, Marek BORSKÝ, Jan OPPELT, J. NOVOTNÁ, Kateřina AMRUZ ČERNÁ, Kateřina MUSILOVÁ, Václav ŠEDA, Yvona BRYCHTOVÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ, Jiří MAYER and Marek MRÁZ. CD20 is a direct regulator of B-cell receptor signaling in the microenvironment of chronic lymphocytic leukemia. 2018.

Basic information

• Original name: CD20 is a direct regulator of B-cell receptor signaling in the microenvironment of chronic lymphocytic leukemia
• Authors: PAVLASOVÁ, Gabriela (203 Czech Republic, belonging to the institution), Veronika SVOBODOVÁ (203 Czech Republic), Marek BORSKÝ (203 Czech Republic, belonging to the institution), Jan OPPELT (203 Czech Republic, belonging to the institution), J. NOVOTNÁ (203 Czech Republic), Kateřina AMRUZ ČERNÁ (203 Czech Republic, belonging to the institution), Kateřina MUSILOVÁ (203 Czech Republic, belonging to the institution), Václav ŠEDA (203 Czech Republic, belonging to the institution), Yvona BRYCHTOVÁ (203 Czech Republic, belonging to the institution), Michael DOUBEK (203 Czech Republic, belonging to the institution), Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution), Jiří MAYER (203 Czech Republic, belonging to the institution) and Marek MRÁZ (203 Czech Republic, guarantor, belonging to the institution).
• Edition: 2018.

Other information

• Original language: English
• Type of outcome: Conference abstract
• Field of Study: 10606 Microbiology
• Confidentiality degree: is not subject to a state or trade secret
• RIV identification code: RIV/00216224:14740/18:00104060
• Organization unit: Central European Institute of Technology
• Keywords in English: CD20; receptor; microenvironment; CLL
• Tags: rivok

Abstract

CD20 is a direct regulator of B-cell receptor signaling in the microenvironment of chronic lymphocytic leukemia, CD20 is a direct regulator of B-cell receptor signaling in the microenvironment of chronic lymphocytic leukemia.

Links

• LQ1601, research and development project: Name: CEITEC 2020 (Acronym: CEITEC2020)

Investor: Ministry of Education, Youth and Sports of the CR

• MUNI/A/0968/2017, interní kód MU: Name: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit V (Acronym: VýDiTeHeMA V)

Investor: Masaryk University, Category A

• MUNI/H/0865/2016, interní kód MU: Name: Coding and Non-coding RNA Networks that Regulate B Cell Receptor Signalling: Implications for Combinatorial Therapy

Investor: Masaryk University, Individual High risk/high gain projects

• NV16-29622A, research and development project: Name: VLIV TERAPEUTICKÉ INHIBICE BCR SIGNALIZACE NA GENOVOU EXPRESI U B BUNĚČNÝCH MALIGNIT A JEJÍ PROGNOSTICKÝ A PREDIKTIVNÍ VÝZNAM
• 692298, interní kód MU: Name: MEDGENET - Medical genomics and epigenomics network (Acronym: MEDGENET)

Investor: European Union, Spreading excellence and widening participation